Directly below you’ll find the brief overview I promised of the new university medical study which amply demonstrates colloidal silver’s incredible effectiveness against fungal pathogens of the Candida and Trichophyton species.

It is too bad the U.S. medical community refuses to embrace this vital, peer-reviewed information. If they did, they could pretty much help put an end to today’s growing epidemic of fungal infections, which can cause diseases ranging from Chronic Fatigue Syndrome and fibromyalgia to serious immune system deficiencies, cancer and other life-threatening conditions.

The intransigence of the medical community in regards to its refusal to embrace colloidal silver even in the face of a growing body of new studies proving its effectiveness is due chiefly to the overwhelming influence wielded by the huge multi-billion dollar pharmaceutical corporations. Big Pharma simply does not want to see any relatively inexpensive, safe and natural nutritional supplement competing with their expensive and potentially harmful prescription antifungal, antiviral and antibiotic drugs.

So that’s where things stand. And it is largely why bureaucrats in the U.S. EPA and FDA are working so hard to re-classify beneficial silver nanoparticles (read: colloidal silver) as a “pesticide,” so they can regulate this safe, natural substance into oblivion at the behest of the big pharmaceutical companies. (See the latest blog post on this topic here.)

They don’t want you to know what researchers in other parts of the world are confirming in droves, i.e., that safe, natural colloidal silver is simply the most powerful natural pathogen killer on the face of the earth.

----------------------------------------------------------------------------------------

J Microbiol Biotechnol. 2008 Aug;18(8):1482-4.

Antifungal effect of silver nanoparticles on dermatophytes.Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. Department of Microbiology, College of Natural Scienes, Kyungpook National University, Daegu 702-701, Korea.

Spherical silver nanoparticles (nano-Ag) were synthesized and their antifungal effects on fungal pathogens of the skin were investigated.

Nano-Ag showed potent activity against clinical isolates and ATCC strains of Trichophyton mentagrophytes and Candida species (IC80, 1-7 microg/ml).

The activity of nano-Ag was comparable to that of amphotericin B, but superior to that of fluconazole (amphotericin B IC80, 1-5 microg/ml; fluconazole IC80, 10- 30 microg/ml).

Additionally, we investigated their effects on the dimorphism of Candida albicans. The results showed nano-Ag exerted activity on the mycelia.

Thus, the present study indicates nano-Ag may have considerable antifungal activity, deserving further investigation for clinical applications.